Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug;1(1):10-24.
doi: 10.1007/s13300-010-0004-6. Epub 2010 Sep 13.

The OmniPod Insulin Management System: the latest innovation in insulin pump therapy

Howard C Zisser  1
Affiliations

The OmniPod Insulin Management System: the latest innovation in insulin pump therapy

Howard C Zisser. Diabetes Ther. 2010 Aug.

Abstract

This review of insulin pump therapy focuses on the OmniPod® Insulin Management System (Insulet Corp., Bedford, MA, USA). The OmniPod System is the first commercially available "patch pump." It is a fully integrated wearable pump, controlled wirelessly through a handheld device containing a built-in blood glucose meter. This is an evaluation of the OmniPod System, with the aim of providing an educational tool for physicians who are considering recommending this product to their patients. The review includes a discussion of the traditional insulin pump configuration and its limitations, a detailed overview of the OmniPod System, references to clinical study data, planned product enhancements, its use as an insulin delivery system in the Juvenile Diabetes Research Foundation's Artificial Pancreas Project, and its use to deliver additional compounds.

Keywords: continuous glucose monitor; continuous subcutaneous insulin infusion; insulin pump; multiple daily injections; patch pump; wireless pump.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Zisser H.C., Jovanovič L. OmniPod Insulin Management System: patient perceptions, preference, and glycemic control. Diabetes Care. 2006;29:2175. doi: 10.2337/dc06-0986. - DOI - PubMed
    1. Zisser H.C. Quantifying the impact of a short-interval interruption of insulin-pump infusion sets on glycemic excursions. Diabetes Care. 2008;31:238–239. doi: 10.2337/dc07-1757. - DOI - PubMed
    1. Zisser H.C., Bevier W., Dassau E., Jovanovič L. Siphon effects on continuous subcutaneous insulin infusion pump delivery performance. J Diabetes Sci Technnol. 2010;4:98–103. - PMC - PubMed
    1. Kane M.P., Abelseth J.M., Davis K., Hogan E., Hamilton R.A. Clinical experience with a tubingfree insulin pump system. Infusystems USA. 2009;6:25–27.
    1. Dilanni S, Garibotto J. An innovative application of shape memory alloy (SMA) technology yields a novel therapeutic approach to diabetes management. Insulet Corporation. 2006:12028–AW. Rev 2/04/09.

LinkOut - more resources